Investor Rice Hall James & Associates, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Rice Hall James & Associates, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-05-01 13G/A TRAK / ReposiTrak, Inc. 1,016,408 853,131
2025-02-03 13G CNTY / Century Casinos, Inc. 1,408,036 1,588,310
2024-02-14 13G/A TRAK / ReposiTrak, Inc. 1,050,641 1,016,408
2023-02-14 13G/A CNTY / Century Casinos, Inc. 1,577,227 1,408,036
2023-02-14 13G/A TRAK / ReposiTrak, Inc. 1,040,990 1,050,641
2022-02-14 13G PCYG / Park City Group, Inc. 1,040,990
2022-02-14 13G/A CNTY / Century Casinos, Inc. 1,857,633 1,577,227
2022-02-14 13G/A PCOM / Points.com Inc 890,213 716,628
2022-02-14 13G/A WLDN / Willdan Group, Inc. 617,524 543,980
2021-02-16 13G/A WLDN / Willdan Group, Inc. 670,145 617,524
2021-02-16 13G/A PCOM / Points.com Inc 813,483 890,213
2021-02-16 13G/A CNTY / Century Casinos, Inc. 2,022,340 1,857,633
2021-02-16 13G/A CEVA / CEVA, Inc. 1,308,676 993,898
2021-02-16 13G/A US0909311062 / BioSpecifics Technologies Corp. 369,146 0
2020-02-11 13G US0909311062 / BioSpecifics Technologies Corp. 369,146
2020-02-11 13G PCOM / Points.com Inc 813,483
2020-02-11 13G WLDN / Willdan Group, Inc. 670,145
2020-02-11 13G/A CEVA / CEVA, Inc. 1,254,019 1,308,676
2020-02-11 13G CNTY / Century Casinos, Inc. 2,022,340
2019-02-14 13G CEVA / CEVA, Inc. 1,254,019